Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome
Joseph Sullivan, MD, Professor, UCSF School of Medicine, San Francisco, CA, describes encouraging results from the SWALLOWTAIL and LONGWING studies of an investigational treatment for individuals with Dravet syndrome, including outcomes related to seizure frequency, cognition, and behavior.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from NeuroFrontiers
Generalized Myasthenia Gravis: Inside the MINT Trial and CD19 B-Cell Therapy Advances
The Use of Intracranial Vessel Wall MRI for the Diagnosis of Vasculitis
Ocrevus Treatment in Pregnant and Lactating Women with Multiple Sclerosis
New Guidelines for the Assessment of Traumatic Brain Injury
Get summaries like this every morning.
Free AI-powered recaps of NeuroFrontiers and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.